Neurosense Therapeutics News - October 21, 2026
🟢 Neurosense Therapeutics is trading 12.4% up today amid biotech strength, with no direct catalyst confirmed
Neurosense Therapeutics is trading at $2.63, up +12.39%, alongside biotech-sector strength, though no direct company-specific catalyst was confirmed for the...
🟢 Neurosense Therapeutics is trading 19.66% up in pre-market, with no confirmed company-specific catalyst
Neurosense Therapeutics is trading 19.66% up in pre-market at $2.80, with biotech-sector strength reported as supportive context but not a confirmed direct...
🟢 Neurosense Therapeutics is trading 9.83% up in pre-market with sector support; cause remains unclear
Neurosense Therapeutics is trading $2.57, up 9.83% in pre-market, with biotech-sector strength providing support while the specific trigger remains unclear. -...